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1. Introduction 
The mechanisms involved in the expression of 
biological activity of lutropin have been extensively 
studied [l] and, analogous to other peptide hormones, 
the initial step is believed to involve binding of the 
hormone to a specific receptor located in the plasma 
membrane of the target cells. The specificity and 
characteristics of hormone binding to testicular [ 1 ] 
and ovarian [2] receptors have been investigated and 
preparations of partially purified receptor are 
available [2-41. Little is known, however, about the 
fate of the hormone-receptor complex and its 
relationship, if any, to the termination of biological 
activity. Interestingly, it has recently been reported 
that the number of rat testicular gonadotropin 
receptors decreased with time following injection of 
either lutropin or choriogonadotropin [5]. 
Studies in this laboratory have been concerned 
with the kinetics and mechanisms of plasma clearance 
and biotransformations of lutropin [6-IO]. The 
results of in vivo studies on the kinetics of lutropin 
uptake and catabolism by target tissue are presented 
in the present communication. As expected, tritium 
labeled ovine lutropin binds specifically to the testes 
following intravenous injection into mature male 
rats. From sucrose gradient centrifugation, it appears 
that at least some of the hormones which are bound 
to Leydig cells are internalized and eventually 
degraded by lysosomes. This phenomenon suggests a 
possible mechanism for terminating hormone action 
by target cells and may be important in the regulation 
of lutropin receptors by the gonadotropin itself. 
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2. Materials and methods 
Ovine pituitary lutropin, with a potency of 
1.97 X NIH-LHS18 (95% confidence limits = 
1.27-3.53) was a-highly purified product prepared 
and assayed as described elsewhere [7,1 l] . Tritium 
labeling by reductive methylation to give a highly 
active product containing [3H]monomethyllysine 
and [3H]dimethyllysine was conducted using the 
method given earlier [ 121. After gel-filtration, the 
[mefhyl-3H]lutropin used in these studies had a 
specific radioactivity of 20.8 Ci/mmol and a potency 
of 1.93 X unlabeled lutropin (95% confidence limits = 
1.76-2.12), i.e., 3.8 U/mg. 
Total acid phosphatase (EC 3.1.3.2) activity was 
measured in 0.1% (w/v) Triton X-l 00 using p-nitro- 
phenylphosphate (Sigma) as substrate and monitoring 
the absorbance at 405 nm for p-nitrophenol produc- 
tion. The reaction conditions and reagents represented 
slight modifications [ 131 of existing methods [ 14,151. 
Free acid phosphatase activity was measured by a 
standard assay [ 16,171. The activity of 5’nucleotidase 
(EC 3.1.3.5) was determined as the difference in the 
amount of inorganic phosphate released from sodium 
5’-AMP (Sigma) in the absence and presence of 25 I.IM 
cY,f3-methylene-5’-ADP ( -L Biochemicals). The reac- 
tion was carried out as described elsewhere [ 131 
and terminated by the addition of 10% (w/v) TCA. 
The samples were centrifuged and the inorganic 
phosphate released was measured in the supernatant 
[lg] . o@Methylene-5’-ADP is a competitive inhibitor 
of 5’nucleotidase [ 191 and its incorporation into the 
enzymic assay permits the specific measurement of the 
77 
Volume 75, number 1 FEBS LETTERS March 1977 
enzyme in the presence of non-specific phosphatases 
[20]. Protein was measured by the method of Lowry 
et al. [21] using bovine serum albumin as standard. 
Mature male rats were injected intravenously [7], 
generally with 50 pg [methyl-3H]lutropin, and 
sacrificed at the times indicated. The testes were 
removed, decapsulated, placed on ice, and washed 
with cold 0.25 M sucrose, 10 mM Tris-HCl, pH 7.4. 
Homogenization was carried out in the same medium 
using 50 strokes of the tight pestle of a Dounce 
homogenizer. Initially, subcellular fractions were 
prepared by the method of Mego and McQueen [22]. 
Sucrose-gradients were prepared at room tempera- 
ture using a Beckman Density Gradient Former and 
were stored at 4°C for 18 h prior to use. The testicular 
particulate fraction (27 000 X g, 15 min) 0.5 ml in 
Tris-buffered sucrose, was carefully layered on 12.5 ml 
gradients and centrifuged at 35 000 rev./min for 2 h 
in a Beckman L2-65B ultracentrifuge at 4°C with a 
SW41 rotor. Thirteen fractions (1 .O ml each) were 
collected from the top using a Buchler Autodensiflow 
and analyzed for radioactivity and enzymic activity. 
Refractive index measurements on control gradients 
without tissue established fraction densities. 
Discontinuous sucrose gradient centrifugation was 
performed using a Beckman 60 Ti rotor at 3 1 000 
rev./min for 60 min at 4°C. The testicular particulate 
fraction was resuspended by homogenization in 20 ml 
59.9% sucrose @ = 1.22 g/ml). Thirteen ml of this 
suspension were placed in a 30 ml centrifuge tube 
and overlayered with 10 ml 48.45% sucrose 
(‘J = 1.18 g/ml), followed by a 4 ml layer of 42.9% 
sucrose (p = 1.16 g/ml). All sucrose solutions con- 
tained 1 mM CaClz and %-solution refers to w/v. 
Fractions of 2 ml were collected. 
Total and TCA-soluble radioactivity were deter- 
mined as described elsewhere [7]. TCA-soluble 
products were prepared using techniques given else- 
where [ 131 and the separation of amino acids from 
oligopeptides was accomplished using copper- 
Sephadex chromatography [23 ] . 
Disruption of subcellular fractions by Triton X-100 
and osmotic shock were based on standard methods 
[ 14,241 . Disruption by homogenization was accom- 
plished using a Polytron PT-10 homogenizer at 15 000 
rev./min for 5 min. Afterwards, the particles were cen- 
trifuged at 27 000 X g for 20 min and the supernatant 
was assayed for radioactivity and enzymic activity. 
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Leydig cells were prepared from collagenase 
(Worthington) dispersed testis as described earlier [7]. 
3. Results 
An accurate measurement of the amount of radio- 
activity taken up by testes under in vivo conditions is 
difficult because the blood cannot be readily removed 
from the tissue. To avoid this problem, all the experi- 
ments were performed using a 27 000 X g (15 min) 
pellet which was found to contain 97% of the radio- 
activity associated with testicular particulate material 
15 min after an injection of 50 pg [mefhyl-3H]lutropin 
into mature rats. The 27 000 X g (15 min) pellet 
contained 40% of the protein, 80% of the acid phos- 
phatase activity (marker for lysosomes) and 60% of 
the 5’-nucleotidase activity (marker for plasma 
membranes), relative to the testicular homogenate. 
The radioactivity associated with this particulate 
fraction accounted for 30-50% of that present in 
the testicular homogenate, and it can be competitively 
diluted out by injecting [methyZ-3H]lutropin simul- 
taneously with unlabeled hormone as shown in table 1. 
The association of the hormone with this fraction is 
thus considered specific. Most of the radioactivity that 
is not associated with the particulate fraction is TCA- 
soluble and is believed to arise mainly from the trapped 
blood which contains tritiated amino acids from 
non-target tissue catabolism of [methyl-3H]lutropin 
[7,81. 
Figure 1A shows the total radioactivity associated 
with the testicular particulate fraction at various 
times after injection of [methyl-‘Hllutropin. The 
Table 1 
Competition of the testicular uptake (particulate fraction) of 
tritiated lutropin by unlabeled hormonea 
Lutropin injected (pg) dpm/peUetb 
0 6640 
10 3152 
90 800 
a In all cases 10 ug of [mefhyl-3H]lutropin were injected 
simultaneously with lutropin. The animals were sacrificed 
15 min after injection and the testes were removed, 
homogenized, and centrifuged at 27 000 X g for 15 min. 
The pellet was resuspended in 5 ml 0.25 M sucrose and 
0.5 ml aliquots were counted. 
b Each pellet contained approx. 30 mg protein. 
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Fig.1. Target tissue uptake of lutropin; rats were injected with 50 pg [meGryl-3H]lutropin at time zero. The testicular 27 000 X g 
(15 min) pellet was homogenized and the total and TCA-soluble radioactivity was determined. (A) The tOta radioactivity at 
various times post-injection. (B) Percentage of the total radioactivity in (A) that is TCA-soluble. 
maximum appears to occur at about 15 min. This is 
similar to that observed in liver and kidneys [6-81. 
Between 15 min and 60 min, the amount of TCA- 
soluble radioactivity in this fraction increased from 
less than 4% to greater than 20% of the total 
particulate-associated ra ioactivity (fig.lB). It is 
noteworthy that this increase occurs during a time 
interval in which the total radioactivity is diminishing. 
The TCA-soluble radioactivity corresponds both to 
single amino acids and oligopeptides as shown by 
copper-Sephadex chromatography (fig.2). These 
.J 
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Fig.2. Analysis of the TCA-soluble products from the 
testicular 27 000 X g (15 min) particulate fraction, obtained 
60 min after injection of [methyl-‘HJlutropin, using copper- 
Sephadex chromatography. Peptides elute between 25-35 ml 
and amino acids elute between loo-115 ml. 
results demonstrate hat testicular tissue can degrade 
the hormone that is bound under in vivo conditions. 
In an effert to separate the plasma membrane and 
lysosomal fractions, the testicular 27 000 X g (15 Tin) 
pellet was analyzed on a 17-56% sucrose-gradient 
which resolves these subcellular f actions in other 
tissues [17,25]. Based on the activity of acid phos- 
phatase and 5’.nucleotidase, there was no evidence of 
separation of the two subcellular f actions in the 
testicular material. The activities of both enzymes, as 
well as the radioactivity at 5 min and 60 min follow- 
ing an injection of [methyl-3H]lutropin, banded 
between the densities 1.16 g/ml and 1.22 g/ml [ 131. 
Partial separation of the testicular plasma mem- 
brane and lysosomal fraction was accomplished with 
a 40-60% sucrose gradient. Two major protein bands 
were observed when the testicular pellet was analyzed 
on this gradient. The first band occurred about 0.5 cm 
from the top of the gradient and contained most of 
the 5’-nucleotidase activity. The second band was 
located about 7 cm from the top and contained 
most of the acid phosphatase activity. The results, 
obtained by first preparing Leydig cells and then the 
particulate fraction, are shown as a density distribu- 
tion [17,25] in fig.3 along with the density distribu- 
tion of radioactivity 5 tin and 60 min after injection 
of [methyl-3H]lutropin. With increasing time after 
injection of the labeled hormone, there is a migration 
of radioactivity toward higher density suggesting a 
translocation from the plasma membrane fraction to 
the lysosomal fraction. A similar movement of radio- 
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Fig.3. Subfractionation of the Leydig cell 27 000 X g 
(15 min) pellet on a 40-60% sucrose-gradient. The density 
distribution of acid phosphatase and S’nucleotidase is shown 
in the upper panels. These represent he average of 2 gradients 
and material from 2 animals was used in each gradient. The 
lower panels show the density distribution of radioactivity 
5 min and 60 min after injection of 50 ng [methyl-sH] 
lutropin. 
activity with time after injection of [methyL3H] 
lutropin was observed using a discontinuous sucrose 
gradient of the (total) testicular pellet and the results 
are summarized in table 2. 
The structural latency of lysosomal enzymes can 
be released by various treatments [ 13,14,17,24,2 . 
Several of these treatments have been used on the 
testicular particulate fraction, isolated 5 min and ? 
60 min after injection of [methyl-3H]lutropin, and’ 
the results are summarized in table 3, It can be seen 
that 2-3 times more radioactivity can be released 
from the 60 min fraction than from the 5 min fraction, 
These results are consistent with the hypothesis that 
the lysosomes are responsible for catabolizing lutropin 
in male target-tissue. 
Table 2 
Relative distribution of acid phosphatase, S’nucleotidase and 
radioactivity from the testicular particulate fraction in a 
discontinuous sucrosegradienta 
Constituent at Relative activityb 
sucrose-interface 
(Fractions l-3) (Fractions 7-9) 
Enzymic activity: 
Acid phosphatase 0.88 1.06 
5’-Nucleotidase 1.56 0.74 
Radioactivity: 
5 min 1.34 0.83 
60 min 0.72 1.13 
a The testicular 27 000 X g (15 min) pellet was analyzed 
using the discontinuous sucrose-gradient as described in 
Materials and methods. 
b The values given represent he relative amount of the 
constituent at each sucrose-interface calculated as follows. 
Enzymic activities, radioactivities and total protein in 
pooled fractions l-3 and pooled fractions 7-9 were each 
normalized to unity and the values given represent he 
enzymic- or radioactivity relative to the protein content. 
The protein content of combined fractions 7-9 was about 
twice that of combined fractions l-3. At time zero, 50 pg 
[methyl-sH]lutropin was injected and one group of animals 
was sacrificed 5 min later and another group 60 min later. 
4. Discussion 
Our results are consistent with the following model. 
After binding of lutropin to a specific receptor on the 
Leydig cell plasma membrane and (probable) subse- 
quent cellular activation, the hormone-receptor 
complex is internalized, presumably via endocytosis, 
Table 3 
Release of radioactivity from the testicular 27 000 X g 
(15 min) pellet 5 min and 60 min after injection of 50 fig 
[methyE3H]lutropin 
Treatmenta Radioactivity released (% total) 
Smin 60 min 
Osmotic shock 9.8 30.0 
0.1% (w/v) Triton X-100 25.0 52.0 
Homogenization 6.0 21.0 
a Each of these treatments released 95-100% of the acid 
phosphatase activity and 2-S% of the 5’-nucleotidase 
activity 
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and the endocytic vesicles fuse with primary lysosomes 
where catabolism then occurs. There is no firm 
evidence on the fate of the receptor. The suggestion 
that it may also be internalized is based on the 
following information. Binding of lutropin to the 
plasma membrane of target-tissue (i.e., Leydig cells 
in males) seems to be a prerequisite for internaliza- 
tion; moreover, the membrane surrounding the 
endocytic vesicle is believed to arise from the plasma 
membrane [26,27]. Also, Hsueh et al. found that the 
presence of gonadotropins leads to an apparent 
decrease in the number of receptors [S] . 
Midgley and coworkers have proposed a similar 
model to explain their autoradiographic results on the 
in vivo interaction of iodinated human choriogonado- 
tropin with the ovaries of pseudopregnant rats [28]. 
However, their observations could not be confirmed 
by following the distribution of radioactivity and 
subcellular organelles by sucrose-gradient centrifuga- 
tion since a good separation was not achieved between 
the plasma membrane and lysosomal fractions [29]. 
A similar mechanism was also proposed to explain the 
interaction of epidermal growth factor with cultured 
human fibroblasts [30]. Lastly, the observations that 
the number of receptor sites for growth hormone 
and insulin in cultured human lymphocytes are 
regulated by the extracellular concentration of the 
hormones [31,32] and the apparent regulation of the 
number of receptors in pituitary cells by thyrotropin 
releasing factor [33] , are consistent with this model. 
The proposed model provides an efficient and 
general pathway by which the action of peptide and 
glycoprotein hormones can be terminated. No infor- 
mation is available on whether the process of inter- 
nalization has associated biological actions, or if it 
serves mainly to terminate hormone action and to 
regulate the number of receptors. 
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